SenzaGen AB (STO:SENZA)
Sweden · Delayed Price · Currency is SEK 5.44
-0.06 (-1.09%)
At close: Mar 4, 2026
SenzaGen AB Revenue
In the year 2025, SenzaGen AB had annual revenue of 57.97M SEK with 0.48% growth. SenzaGen AB had revenue of 15.58M in the quarter ending December 31, 2025, with 0.62% growth.
Revenue
57.97M
Revenue Growth
+0.48%
P/S Ratio
3.05
Revenue / Employee
1.61M
Employees
36
Market Cap
176.84M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.97M | 279.00K | 0.48% |
| Dec 31, 2024 | 57.70M | 7.83M | 15.69% |
| Dec 31, 2023 | 49.87M | 8.10M | 19.39% |
| Dec 31, 2022 | 41.77M | 26.35M | 170.85% |
| Dec 31, 2021 | 15.42M | 7.46M | 93.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.97B |
| Swedish Orphan Biovitrum AB | 28.24B |
| Medicover AB | 25.74B |
| Sectra AB | 3.47B |
| Magle Chemoswed Holding AB | 300.49M |
| Subgen AI AB | 228.08M |
| Sprint Bioscience AB | 167.17M |
| Clinical Laserthermia Systems AB | 17.49M |
SenzaGen AB News
- 4 months ago - SenzaGen AB (SZGEF) Analyst/Investor Day Transcript - Seeking Alpha